GlaxoSmithKline PLC Total Voting Rights (8827O)
01 Febrero 2019 - 9:45AM
UK Regulatory
TIDMGSK
RNS Number : 8827O
GlaxoSmithKline PLC
01 February 2019
GlaxoSmithKline plc
Total Voting Rights and Capital
In conformity with the Financial Conduct Authority's Disclosure
Guidance and Transparency Rule 5.6.1R, GlaxoSmithKline plc (the
'Company') hereby notifies the market of the following:
The Company's issued share capital as at 31 January 2019
consisted of 5,379,528,456 shares of 25 pence each ('Ordinary
Shares'), of which 414,605,950 Ordinary Shares were held in
Treasury.
Therefore, the total number of voting rights in the Company is
4,964,922,506. This figure may be used by shareholders as the
denominator for the calculations by which they will determine if
they are required to notify their interest in, or a change to their
interest in, the Company under the Financial Conduct Authority's
Disclosure Guidance and Transparency Rules.
V A Whyte
Company Secretary
1 February 2019
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
TVREALAFELANEFF
(END) Dow Jones Newswires
February 01, 2019 10:45 ET (15:45 GMT)
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024